General Counsel
Rigel Pharmaceuticals Inc (RIGL)Equibles does not estimate personal net worth.
Get an email with a short summary when Rigel Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get RIGL alertsRay Furey is recorded as General Counsel at Rigel Pharmaceuticals Inc (RIGL). Ray Furey has spoken on 10 earnings calls and 1 other investor event across 1 company, most recently for Rigel Pharmaceuticals Inc on November 5, 2026. Rigel Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rigel Pharmaceuticals Inc includes Raul R. Rodriguez (CEO and Board Member), Raul Rodriguez (CEO and Board Member), Dean Schorno (CFO) and 7 others.
“The financial press release for the third quarter 2026 was issued earlier today and can be viewed, along with the slides for this presentation, in the news and events section of our investor relations site on Rigel.com. As a reminder, during today's call, we may make forward-looking statements regarding our financial…”
“The financial press release for the second quarter 2026 was issued earlier today and can be viewed along with the slides for this presentation in the news and events section of our investor relations site on Rigel.com. As a reminder, during today's call, we may make forward-looking statements regarding our financial…”
“Welcome to our conference call to discuss Rigel's in-licensing of VEPANU, or VEPDESICRANT.”
“The financial press release for the first quarter of 2026 was issued a short while ago and can be viewed along with the slides for this presentation in the news and events section of our investor relations site on Rigel.com. as a reminder during today's call we may make forward-looking statements regarding our…”
“The financial press release for the first quarter 2025 was issued a short while ago and can be viewed along with the slides for this presentation in the News and Events section of our Investor Relations site on rigel.com. As a reminder, during today's call, we may make forward-looking statements regarding our…”
Biotechnology · Healthcare
General Counsel
